• 제목/요약/키워드: Imaging guidelines

검색결과 146건 처리시간 0.026초

인디음악에 사용되는 애니메이션(GLOOM) 제작에 대한 연구 (A study on the production of animated GLOOM used in indie music)

  • 김태은
    • 디지털콘텐츠학회 논문지
    • /
    • 제18권8호
    • /
    • pp.1495-1500
    • /
    • 2017
  • Low poly기법을 기반으로 제작된 애니메이션 Gloom은 무명가수의 언더그라운드 음원을 애니메이션으로 표현하여 제작 의도를 표현한다. 본 논문은 모델링 과정, 리깅 과정, 애니메이션 과정, 렌더링 과정을 포함하는 애니메이션의 제작과정에 대해 다루고 있다. 음원을 의뢰자의 의도에 맞게 순수 창작 애니메이션으로 제작하는 과정을 심도 있게 고찰함으로써, 결과적으로 유사 창작 작업을 하는 순수 창작자들에게 가이드라인을 제공할 수 있을 것으로 생각된다.

Gallbladder polyps: evolving approach to the diagnosis and management

  • Kim, Kook Hyun
    • Journal of Yeungnam Medical Science
    • /
    • 제38권1호
    • /
    • pp.1-9
    • /
    • 2021
  • Gallbladder (GB) polyp is a mucosal projection into the GB lumen. With increasing health awareness, GB polyps are frequently found using ultrasonography during health screening. The prevalence of GB polyps ranges between 1.3% and 9.5%. Most patients are asymptomatic and have benign characteristics. Of the nonneoplastic polyps, cholesterol polyps are most common, accounting for 60%-70% of lesions. However, a few polyps have malignant potential. Currently, the guidelines recommend laparoscopic cholecystectomy for polyps larger than 1 cm in diameter due to their malignant potential. The treatment algorithm can be influenced by the size, shape, and numbers of polyps, old age (>50 years), the presence of primary sclerosing cholangitis, and gallstones. This review summarizes the commonly recognized concepts on GB polyps from diagnosis to an algorithm of treatment.

Diagnosis of Nonmigrating Metallic Foreign Bodies in the Abdomen Using Ultrasound: An Alternative Approach Using a Traditional Method

  • Pak, Seong Min;Lee, Yeoun Joo;Hwang, Jae Yeon
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제25권1호
    • /
    • pp.87-91
    • /
    • 2022
  • Ingestion of foreign bodies (FBs) is a common phenomenon among young children. Plain radiography is the first step diagnostic modality to detect the radio-opaque FBs. And computed tomography has been recommended by several guidelines as useful modalities for diagnosing ingested FBs. However, there is a risk of radiation exposure, making it burdensome to use in asymptomatic patients. Ultrasound (US) is not a commonly used technique for diagnosing ingested foreign bodies. However, US can provide real-time imaging with good resolutions without radiation exposure in pediatric patients. Herein, we report two pediatric cases of metallic foreign body ingestion that were successfully diagnosed using US for localizing foreign bodies. This study indicates that US may be used as an alternative method for detecting the localization of metallic foreign bodies in the gastrointestinal tract without exposure of radiation, particularly in pediatric patients.

Beyond BI-RADS: Nonmass Abnormalities on Breast Ultrasound

  • Hiroko Tsunoda;Woo Kyung Moon
    • Korean Journal of Radiology
    • /
    • 제25권2호
    • /
    • pp.134-145
    • /
    • 2024
  • Abnormalities on breast ultrasound (US) images which do not meet the criteria for masses are referred to as nonmass lesions. These features and outcomes have been investigated in several studies conducted by Asian researchers. However, the term "nonmass" is not included in the American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS) 5th edition for US. According to the Japan Association of Breast and Thyroid Sonology guidelines, breast lesions are divided into mass and nonmass. US findings of nonmass abnormalities are classified into five subtypes: abnormalities of the ducts, hypoechoic areas in the mammary glands, architectural distortion, multiple small cysts, and echogenic foci without a hypoechoic area. These findings can be benign or malignant; however, focal or segmental distributions and presence of calcifications suggest malignancy. Intraductal, invasive ductal, and lobular carcinomas can present as nonmass abnormalities. For the nonmass concept to be included in the next BI-RADS and be widely accepted in clinical practice, standardized terminologies, an interpretation algorithm, and outcome-based evidence are required for both screening and diagnostic US.

2021 Korean Thyroid Imaging Reporting and Data System and Imaging-Based Management of Thyroid Nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations

  • Eun Ju Ha;Sae Rom Chung;Dong Gyu Na;Hye Shin Ahn;Jin Chung;Ji Ye Lee;Jeong Seon Park;Roh-Eul Yoo;Jung Hwan Baek;Sun Mi Baek;Seong Whi Cho;Yoon Jung Choi;Soo Yeon Hahn;So Lyung Jung;Ji-hoon Kim;Seul Kee Kim;Soo Jin Kim;Chang Yoon Lee;Ho Kyu Lee;Jeong Hyun Lee;Young Hen Lee;Hyun Kyung Lim;Jung Hee Shin;Jung Suk Sim;Jin Young Sung;Jung Hyun Yoon;Miyoung Choi
    • Korean Journal of Radiology
    • /
    • 제22권12호
    • /
    • pp.2094-2123
    • /
    • 2021
  • Incidental thyroid nodules are commonly detected on ultrasonography (US). This has contributed to the rapidly rising incidence of low-risk papillary thyroid carcinoma over the last 20 years. The appropriate diagnosis and management of these patients is based on the risk factors related to the patients as well as the thyroid nodules. The Korean Society of Thyroid Radiology (KSThR) published consensus recommendations for US-based management of thyroid nodules in 2011 and revised them in 2016. These guidelines have been used as the standard guidelines in Korea. However, recent advances in the diagnosis and management of thyroid nodules have necessitated the revision of the original recommendations. The task force of the KSThR has revised the Korean Thyroid Imaging Reporting and Data System and recommendations for US lexicon, biopsy criteria, US criteria of extrathyroidal extension, optimal thyroid computed tomography protocol, and US follow-up of thyroid nodules before and after biopsy. The biopsy criteria were revised to reduce unnecessary biopsies for benign nodules while maintaining an appropriate sensitivity for the detection of malignant tumors in small (1-2 cm) thyroid nodules. The goal of these recommendations is to provide the optimal scientific evidence and expert opinion consensus regarding US-based diagnosis and management of thyroid nodules.

한국형 흉부 MRI 영상 진단 정당성 권고안 (Korean Clinical Imaging Guidelines for the Appropriate Use of Chest MRI)

  • 송지영;남보다;윤순호;유진영;정연주;여창동;임성용;이승룡;김현구;김병혁;진광남;용환석
    • 대한영상의학회지
    • /
    • 제82권3호
    • /
    • pp.562-574
    • /
    • 2021
  • MRI는 방사선 위험이 없으며, 높은 연조직 대조도 및 기능 정보 획득의 장점을 가지고 있다. 과거 기술적 한계로 흉부 분야에서 MRI의 사용이 제한되었으나, 최근 기술 발전 및 흉부 MRI의 보험 적용 확대로 흉부 MRI의 적응증과 수요가 급증할 것으로 예상된다. 이에 대한 영상의학회는 한국의 의료 실정에 맞는 흉부 MRI의 적절한 활용과 관련된 지침의 개발이 필요하다고 보고 개발위원회, 실무위원회 및 자문위원회의 의견을 모아 한국형 흉부 MRI 정당성 가이드라인을 개발하였다. 5가지 문장형 핵심질문을 선정하고, 근거기반 임상영상 가이드라인 수용개작 방법론에 의거하여 권고안을 작성하였다. 권고 내용은 다음과 같다. 우연히 발견된 전종격동 병변 환자에서 비종양성 질환 진단을 위하여 흉부 MRI를 권장한다. 폐 종괴가 발견된 진폐증 환자에서 악성 종양과 진행성거대섬유증의 감별 진단을 위하여 흉부 MRI를 권장한다. 악성 흉막 중피종 또는 비소세포 폐암 환자에서 흉벽, 척추, 횡격막 또는 혈관 침범이 의심되는 경우 흉부 MRI를 권장한다. 임산부에서 임상적으로 폐색전증이 의심되나, 다른 검사가 불충분할 경우 비조영 흉부 MRI 혹은 중등도 또는 저위험군 조영제를 가능한 최소한의 용량으로 사용하여 조영증강 흉부 MRI를 고려할 수 있다. 폐첨부 폐암 환자에서 근치적 절제술을 고려할 경우 혈관 및 경막 외 공간의 종양 침범을 확인하기 위해 흉부 MRI를 권고한다.

검진 기관에서의 선별 유방촬영술 시행에 따른 연령 제한의 필요성에 대한 연구 (A Study on the Necessity of an Age Limitation in Screening Mammography)

  • 윤하얀;이춘미;안의경;김용환
    • 대한디지털의료영상학회논문지
    • /
    • 제12권1호
    • /
    • pp.33-41
    • /
    • 2010
  • National Cancer Screening Project and Korean Society of Breast Imaging recommend that breast cancer screening should be performed on those aged 40 and above. Nevertheless, this recommendation is usually ignored by a number of medical institutions. The purpose of this study is to emphasize the necessity of an age limitation in screening mammography. Ten institutions were randomly selected and telephone inquiries about patients' age limitation and internal guidelines were set up. The 3,214 women, who underwent screening mammography through 'GE Senography 2000D' in each hospital, were classified into five groups according to age(from 20s to 40s, at intervals of 5). And then, collected data was analyzed by a radiologist in accordance with ACR-BIRADS(American College of Radiology Breast Imaging Reporting and Data System), through which breast parenchymal density and the results of analysis were categorized in order to predict the sensitivity of mammography. Information about craniocaudal-view mammograms was automatically produced by use of GE Senography 2000D, and the average glandular dose was retrospectively analyzed through the program 'Excel 2007.' Two institutions did not set the age limitation. Other seven institutions internally allowed those who wanted to receive mammography regardless of age. Approximately 99% of those aged 20 to 29 were judged as having the dense breast. In those aged 35 to 39, breast parenchymal density tended to be lower, but the fatty breast to increase. In the case of 'category-zero' that does not need additional tests, the rate of 'heterogeneously dense' and 'extremely dense' reached to 83.1% and 15.1% respectively. Regarding dense breasts, there was no sufficient information for image reading. The glandular dose, applied to 3,214, was 1.47mGy on the average. In those aged 20 to 24 who are sensitive to radiation, the average glandular dose indicated 1.59mGy. Those aged 35 and above showed the lowest value, 1.43mGy. In those aged 35 to 39, the breast tended to change from denseness to fattiness. The average glandular dose was lowest in those aged 35 and above, which suggests that screening mammography should be periodically performed on those aged 35 and above in order that breast cancer may be early detected. On the other hand, in those aged less than 35, it is difficult to analyze mammograms due to the high density of breast parenchyma, and also retakes become frequent. In particular, subjects may be exposed to excessive doses. Accordingly, it should be substituted by breast self-examination or clinical breast examination. In case of need, it is advisable to perform ultrasonography.

  • PDF

Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018

  • Sang Min Lee;Jeong Min Lee;Su Joa Ahn;Hyo-Jin Kang;Hyun Kyung Yang;Jeong Hee Yoon
    • Korean Journal of Radiology
    • /
    • 제22권7호
    • /
    • pp.1066-1076
    • /
    • 2021
  • Objective: To evaluate the performance of the 2018 Korean Liver Cancer Association-National Cancer Center (KLCA-NCC) Practice Guidelines (hereafter, PG) for the diagnosis of hepatocellular carcinoma (HCC) using gadoxetic acid-enhanced MRI, compared to the Liver Imaging-Reporting and Data System (LI-RADS) version 2018 (hereafter, v2018). Materials and Methods: From January 2013 to October 2015, treatment-naïve hepatic lesions (≥ 1 cm) on gadoxetic acid-enhanced MRI in consecutive patients with chronic hepatitis B or cirrhosis were retrospectively evaluated. For each lesion, three radiologists independently analyzed the imaging features and classified the lesions into categories according to the 2018 KLCA-NCC PG and LI-RADS v2018. The imaging features and categories were determined by consensus. Generalized estimating equation (GEE) models were used to compare the per-lesion diagnostic performance of the 2018 KLCA-NCC PG and LI-RADS v2018 using the consensus data. Results: In total, 422 lesions (234 HCCs, 45 non-HCC malignancies, and 143 benign lesions) from 387 patients (79% male; mean age, 59 years) were included. In all lesions, the definite HCC (2018 KLCA-NCC PG) had a higher sensitivity and lower specificity than LR-5 (LI-RADS v2018) (87.2% [204/234] vs. 80.8% [189/234], p < 0.001; 86.2% [162/188] vs. 91.0% [171/188], p = 0.002). However, in lesions of size ≥ 2 cm, the definite HCC had a higher sensitivity than the LR-5 (86.8% [164/189] vs. 82.0 (155/189), p = 0.002) without a reduction in the specificity (80.0% [48/60] vs. 83.3% [50/60], p = 0.15). In all lesions, the sensitivity and specificity of the definite/probable HCC (2018 KLCA-NCC PG) and LR-5/4 did not differ significantly (89.7% [210/234] vs. 91.5% [214/234], p = 0.204; 83.5% [157/188] vs. 79.3% [149/188], p = 0.071). Conclusion: For the diagnosis of HCC of size ≥ 2 cm, the definite HCC (2018 KLCA-NCC PG) had a higher sensitivity than LR-5, without a reduction in specificity. The definite/probable HCC (2018 KLCA-NCC PG) had a similar sensitivity and specificity to that those of the LR-5/4.

표준영상의학검사를 대상으로 한 CR과 DR에서의 환자선량평가 (Evaluation of the Patient Dose in Case of Standard Radiographic Examinations Using CR and DR)

  • 김상태;한범희
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제33권3호
    • /
    • pp.173-178
    • /
    • 2010
  • 방사선 일반촬영은 크게 두 가지 유형으로 구분할 수 있는데 디지털 영상 시스템인 CR(Computed Radiography)과 DR(Digital Radiography)이 주로 활용되고 있다. 이 둘의 차이는 선량과 영상의 질 관점에서 정의할 수 있다. 본 연구에는 피부입사선량(Entrance Skin Dose, ESD)의 관점에서 환자에게 투여된 선량을 계산하고 비교하여 CR과 DR 간의 선량 차이를 연구하기 위해 8가지의 표준 영상의학적 검사(Skull AP, Skull LAT, Chest PA, Chest LAT, Abdomen AP, L-spine AP, L-spine LAT, Pelvis AP)가 고려되었다. 영상화질에 대한 평가는 진단방사선학적 영상을 위한 화질 기준에 부합하는지를 보증하기 위해 영상의학과 전문의에 의해 시행되었다. DR의 ESD는 CR의 ESD보다 낮다는 것이 확인되었다. 방사선 촬영을 담당한 방사선사가 동일인 이었고 CR과 DR의 영상 화질이 유사하거나 DR에서 조금 더 우수했기 때문에 본 연구는 고려된 검사 내에서 DR이 CR보다 선량 절감 차원에서 볼 때 더 우수한 기기라는 것을 보여준다.

Comparison of WHO and RECIST Criteria for Evaluation of Clinical Response to Chemotherapy in Patients with Advanced Breast Cancer

  • Khokher, Samina;Qureshi, Muhammad Usman;Chaudhry, Naseer Ahmad
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권7호
    • /
    • pp.3213-3218
    • /
    • 2012
  • When patients with advanced breast cancer (ABC) are treated with neoadjuvant chemotherapy (NACT), efficacy is monitored by the extent of tumor shrinkage. Since their publication in 1981, World Health Organization (WHO) guidelines have been widely practiced in clinical trials and oncologic practice, for standardized tumor response evaluation. With advances in cancer treatment and tumor imaging, a simpler criterion based on one-dimensional rather than bi-dimensional (WHO) tumor measurement, named Response Evaluation Criteria in Solid Tumors (RECIST) was introduced in 2000. Both approaches have four response categories: complete response, partial response, stable disease and progressive disease (PD). Bi-dimensional measurement data of 151 patients with ABC were analysed with WHO and RECIST criteria to compare their response categories and inter criteria reproducibility by Kappa statistics. There was 94% concordance and 9/151 patients were recategorized with RECIST including 6/12 PD cases. RECIST therefore under-estimates and delays diagnosis of PD. This is undesirable because it may delay or negate switch over to alternate therapy. Analysis was repeated with a new criteria named RECIST-Breast (RECIST-B), with a lower threshold for PD (${\geq}10%$ rather than ${\geq}20%$ increase of RECIST). This showed higher concordance of 97% with WHO criteria and re-categorization of only 4/151 patients (1/12 PD cases). RECIST-B criteria therefore have advantages of both ease of measurement and calculations combined with excellent concordance with WHO criteria, providing a practical clinical tool for response evaluation and offering good comparison with past and current clinical trials of NACT using WHO guidelines.